Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Hart

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Gut|August 9, 2024
Age-related patterns of microbial dysbiosis in multiplex inflammatory bowel disease familiesJonathan P Jacobs, Elizabeth A Spencer, Drew S Helmus, et al.
JCI Insight|February 8, 2024
Gene coexpression networks reveal a broad role for lncRNAs in inflammatory bowel diseaseJohn L Johnson, Davit Sargsyan, Eric M Neiman, et al.
BMJ Open Gastroenterology|March 23, 2026
Multiomic characterisation of the clinical efficacy of guselkumab induction therapy in ulcerative colitisAmy Hart, Sunandini Sridhar, Swati Venkat, et al.
Gastroenterology|November 15, 2021
Integrative Analysis of the Inflammatory Bowel Disease Serum Metabolome Improves Our Understanding of Genetic Etiology and Points to Novel Putative Therapeutic TargetsAntonio F Di'Narzo, Sander M Houten, Roman Kosoy, et al.
Nature|November 28, 2024
Gut microbiota strain richness is species specific and affects engraftmentAlice Chen-Liaw, Varun Aggarwala, Ilaria Mogno, et al.
Nature|January 28, 2025
Author Correction: Gut microbiota strain richness is species specific and affects engraftmentAlice Chen-Liaw, Varun Aggarwala, Ilaria Mogno, et al.
ACS Medicinal Chemistry Letters|May 20, 2026
Discovery of BMS-159, an Orally Active Imidazotriazine Pan-CK2 Inhibitor for the Treatment of CancerChristine M Tarby, Amy Hart, Honghe Wan, et al.
Gut|September 15, 2022
Biopsy and blood-based molecular biomarker of inflammation in IBDCarmen Argmann, Ruixue Hou, Ryan C Ungaro, et al.
Frontiers in Immunology|March 27, 2025
Guselkumab binding to CD64<sup>+</sup> IL-23-producing myeloid cells enhances potency for neutralizing IL-23 signalingKacey L Sachen, Deepa Hammaker, Indra Sarabia, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Gut|August 9, 2024
Age-related patterns of microbial dysbiosis in multiplex inflammatory bowel disease familiesJonathan P Jacobs, Elizabeth A Spencer, Drew S Helmus, et al.
JCI Insight|February 8, 2024
Gene coexpression networks reveal a broad role for lncRNAs in inflammatory bowel diseaseJohn L Johnson, Davit Sargsyan, Eric M Neiman, et al.
BMJ Open Gastroenterology|March 23, 2026
Multiomic characterisation of the clinical efficacy of guselkumab induction therapy in ulcerative colitisAmy Hart, Sunandini Sridhar, Swati Venkat, et al.
Gastroenterology|November 15, 2021
Integrative Analysis of the Inflammatory Bowel Disease Serum Metabolome Improves Our Understanding of Genetic Etiology and Points to Novel Putative Therapeutic TargetsAntonio F Di'Narzo, Sander M Houten, Roman Kosoy, et al.
Nature|November 28, 2024
Gut microbiota strain richness is species specific and affects engraftmentAlice Chen-Liaw, Varun Aggarwala, Ilaria Mogno, et al.
Nature|January 28, 2025
Author Correction: Gut microbiota strain richness is species specific and affects engraftmentAlice Chen-Liaw, Varun Aggarwala, Ilaria Mogno, et al.
ACS Medicinal Chemistry Letters|May 20, 2026
Discovery of BMS-159, an Orally Active Imidazotriazine Pan-CK2 Inhibitor for the Treatment of CancerChristine M Tarby, Amy Hart, Honghe Wan, et al.
Gut|September 15, 2022
Biopsy and blood-based molecular biomarker of inflammation in IBDCarmen Argmann, Ruixue Hou, Ryan C Ungaro, et al.
Frontiers in Immunology|March 27, 2025
Guselkumab binding to CD64<sup>+</sup> IL-23-producing myeloid cells enhances potency for neutralizing IL-23 signalingKacey L Sachen, Deepa Hammaker, Indra Sarabia, et al.
Pageof 2